View Item 

Show simple item record

Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience
dc.contributor.authorAl Rifai, Anas
dc.contributor.authorSukul, Nidhi
dc.contributor.authorWonnacott, Robert
dc.contributor.authorHeung, Michael
dc.date.accessioned2018-02-05T16:28:58Z
dc.date.available2019-03-01T21:00:19Zen
dc.date.issued2018-01
dc.identifier.citationAl Rifai, Anas; Sukul, Nidhi; Wonnacott, Robert; Heung, Michael (2018). "Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience." Hemodialysis International 22(1): 50-55.
dc.identifier.issn1492-7535
dc.identifier.issn1542-4758
dc.identifier.urihttps://hdl.handle.net/2027.42/141192
dc.description.abstractIntroduction: Arteriovenous fistula or graft (AVF/AVG) use is widely considered contraindicated for continuous renal replacement therapy (CRRT), yet insertion of hemodialysis (HD) catheters can carry high complication risk in critically ill end‐stage renal disease (ESRD) patients.Methods: Single‐center analysis of 48 consecutive hospitalized ESRD patients on maintenance HD who underwent CRRT using AVF/AVG from 2012 to 2013. Primary outcome was access‐related complications.Findings: Mean age was 60 years, 48% were male, and 88% required vasopressor support. Median duration of AVF/AVG use for CRRT was 4 days (range 1–34). Ten (21%) patients had access complications (5 bleeding, 5 infiltration, 1 thrombosis); 5 (10.4%) required catheter placement. Overall 31 (65%) patients survived to hospital discharge and AVF/AVG access was functional at the time of discharge in 29 (94%) patients.Discussion: In our experience, use of AVF/AVG for CRRT can be performed with a low serious complication rate and low risk of access loss, potentially avoiding catheter‐related complications.
dc.publisherWiley Periodicals, Inc.
dc.publisherNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2015
dc.subject.otherCRRT
dc.subject.otherarteriovenous graft
dc.subject.otherarteriovenous fistula
dc.subject.otherpatient safety
dc.titleSafety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141192/1/hdi12550_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141192/2/hdi12550.pdf
dc.identifier.doi10.1111/hdi.12550
dc.identifier.sourceHemodialysis International
dc.identifier.citedreferenceVijayan A. Vascular access for continuous renal replacement therapy. Semin Dial. 2009; 22: 133 – 136.
dc.identifier.citedreferenceUnited States Renal Data System. 2015. USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2015.
dc.identifier.citedreferenceD’Agata EM, Mount DB, Thayer V, et al. Hospital‐acquired infections among chronic hemodialysis patients. Am J Kidney Dis. 2000; 35: 1083 – 1088.
dc.identifier.citedreferenceBlaivas M. Video analysis of accidental arterial cannulation with dynamic ultrasound guidance for central venous access. J Ultrasound Med. 2009; 28: 1239 – 1244.
dc.identifier.citedreferenceHoste EA, Dhondt A. Clinical review: Use of renal replacement therapies in special groups of ICU patients. Crit Care. 2012; 16: 201.
dc.identifier.citedreferenceDavenport A, Mehta S. The acute dialysis quality initiative–part VI: Access and anticoagulation in CRRT. Adv Ren Replace Ther. 2002; 9: 273 – 281.
dc.identifier.citedreferenceSlama M, Novara A, Safavian A, et al. Improvement of internal jugular vein cannulation using an ultrasound‐guided technique. Intensive Care Med. 1997; 23: 916 – 919.
dc.identifier.citedreferenceTroianos CA, Jobes DR, Ellison N. Ultrasound‐guided cannulation of the internal jugular vein. A prospective, randomized study. Anesth Analg. 1991; 72: 823 – 826.
dc.identifier.citedreferenceMansfield PF, Hohn DC, Fornage BD, et al. Complications and failures of subclavian‐vein catheterization. N Engl J Med. 1994; 331: 1735 – 1738.
dc.identifier.citedreferenceDenys BG, Uretsky BF, Reddy PS. Ultrasound‐assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark‐guided technique. Circulation. 1993; 87: 1557 – 1562.
dc.identifier.citedreferenceChang TI, Paik J, Greene T, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011; 22: 1526 – 1533.
dc.identifier.citedreferenceLee T, Barker J, Allon M. Needle infiltration of arteriovenous fistulae in hemodialysis: Risk factors and consequences. Am J Kidney Dis. 2006; 47: 1020 – 1026.
dc.identifier.citedreferenceSouweine B, Traore O, Aublet‐Cuvelier B, et al. Dialysis and central venous catheter infections in critically ill patients: Results of a prospective study. Crit Care Med. 1999; 27: 2394 – 2398.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hdi12550_am.pdf
Size:
317.4KB
Format:
PDF
View/Open
Name:
hdi12550.pdf
Size:
109.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.